1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Saudek, V. Pastore, A. Ramponi, G. Williams, R.J.P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 224 427 440 10.1016/0022-2836(92)91005-A 1313885 Three-dimensional structure of acylphosphatase. Refinement and structure analysis. 1992 UK J.Mol.Biol. JMOBAK 0070 0022-2836 207 405 Identification and Description of Beta-Structure in Horse Muscle Acylphosphatase by Nuclear Magnetic Resonance Spectroscopy 1989 UK J.Mol.Biol. JMOBAK 0070 0022-2836 205 229 Identification and Description of Alpha-Helical Regions in Horse Muscle Acylphosphatase by 1H Nuclear Magnetic Resonance Spectroscopy 1989 10.2210/pdb1aps/pdb pdb_00001aps 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 11032.437 ACYLPHOSPHATASE 3.6.1.7 1 man polymer no no STARPLKSVDYEVFGRVQGVCFRMYAEDEARKIGVVGWVKNTSKGTVTGQVQGPEEKVNSMKSWLSKVGSPSSRIDRTNF SNEKTISKLEYSNFSVRY STARPLKSVDYEVFGRVQGVCFRMYAEDEARKIGVVGWVKNTSKGTVTGQVQGPEEKVNSMKSWLSKVGSPSSRIDRTNF SNEKTISKLEYSNFSVRY A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n horse Equus sample 9796 Equus caballus database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1992-07-15 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1991-02-20 REL REL 5 SER 1 n 1 SER 1 A THR 2 n 2 THR 2 A ALA 3 n 3 ALA 3 A ARG 4 n 4 ARG 4 A PRO 5 n 5 PRO 5 A LEU 6 n 6 LEU 6 A LYS 7 n 7 LYS 7 A SER 8 n 8 SER 8 A VAL 9 n 9 VAL 9 A ASP 10 n 10 ASP 10 A TYR 11 n 11 TYR 11 A GLU 12 n 12 GLU 12 A VAL 13 n 13 VAL 13 A PHE 14 n 14 PHE 14 A GLY 15 n 15 GLY 15 A ARG 16 n 16 ARG 16 A VAL 17 n 17 VAL 17 A GLN 18 n 18 GLN 18 A GLY 19 n 19 GLY 19 A VAL 20 n 20 VAL 20 A CYS 21 n 21 CYS 21 A PHE 22 n 22 PHE 22 A ARG 23 n 23 ARG 23 A MET 24 n 24 MET 24 A TYR 25 n 25 TYR 25 A ALA 26 n 26 ALA 26 A GLU 27 n 27 GLU 27 A ASP 28 n 28 ASP 28 A GLU 29 n 29 GLU 29 A ALA 30 n 30 ALA 30 A ARG 31 n 31 ARG 31 A LYS 32 n 32 LYS 32 A ILE 33 n 33 ILE 33 A GLY 34 n 34 GLY 34 A VAL 35 n 35 VAL 35 A VAL 36 n 36 VAL 36 A GLY 37 n 37 GLY 37 A TRP 38 n 38 TRP 38 A VAL 39 n 39 VAL 39 A LYS 40 n 40 LYS 40 A ASN 41 n 41 ASN 41 A THR 42 n 42 THR 42 A SER 43 n 43 SER 43 A LYS 44 n 44 LYS 44 A GLY 45 n 45 GLY 45 A THR 46 n 46 THR 46 A VAL 47 n 47 VAL 47 A THR 48 n 48 THR 48 A GLY 49 n 49 GLY 49 A GLN 50 n 50 GLN 50 A VAL 51 n 51 VAL 51 A GLN 52 n 52 GLN 52 A GLY 53 n 53 GLY 53 A PRO 54 n 54 PRO 54 A GLU 55 n 55 GLU 55 A GLU 56 n 56 GLU 56 A LYS 57 n 57 LYS 57 A VAL 58 n 58 VAL 58 A ASN 59 n 59 ASN 59 A SER 60 n 60 SER 60 A MET 61 n 61 MET 61 A LYS 62 n 62 LYS 62 A SER 63 n 63 SER 63 A TRP 64 n 64 TRP 64 A LEU 65 n 65 LEU 65 A SER 66 n 66 SER 66 A LYS 67 n 67 LYS 67 A VAL 68 n 68 VAL 68 A GLY 69 n 69 GLY 69 A SER 70 n 70 SER 70 A PRO 71 n 71 PRO 71 A SER 72 n 72 SER 72 A SER 73 n 73 SER 73 A ARG 74 n 74 ARG 74 A ILE 75 n 75 ILE 75 A ASP 76 n 76 ASP 76 A ARG 77 n 77 ARG 77 A THR 78 n 78 THR 78 A ASN 79 n 79 ASN 79 A PHE 80 n 80 PHE 80 A SER 81 n 81 SER 81 A ASN 82 n 82 ASN 82 A GLU 83 n 83 GLU 83 A LYS 84 n 84 LYS 84 A THR 85 n 85 THR 85 A ILE 86 n 86 ILE 86 A SER 87 n 87 SER 87 A LYS 88 n 88 LYS 88 A LEU 89 n 89 LEU 89 A GLU 90 n 90 GLU 90 A TYR 91 n 91 TYR 91 A SER 92 n 92 SER 92 A ASN 93 n 93 ASN 93 A PHE 94 n 94 PHE 94 A SER 95 n 95 SER 95 A VAL 96 n 96 VAL 96 A ARG 97 n 97 ARG 97 A TYR 98 n 98 TYR 98 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A CYS 21 10.60 1 A ASN 93 10.99 2 A PRO 54 10.48 2 A GLU 55 10.43 2 A ILE 75 10.78 3 A VAL 36 11.25 5 A ALA 26 -10.51 5 A VAL 47 10.11 1 A TYR 98 0.109 SIDE CHAIN 2 A TYR 11 0.066 SIDE CHAIN 2 A TYR 25 0.078 SIDE CHAIN 2 A ARG 74 0.103 SIDE CHAIN 3 A TYR 11 0.081 SIDE CHAIN 3 A PHE 94 0.085 SIDE CHAIN 4 A TYR 11 0.145 SIDE CHAIN 4 A PHE 22 0.080 SIDE CHAIN 5 A TYR 11 0.121 SIDE CHAIN 5 A TYR 25 0.133 SIDE CHAIN 1 3.02 0.50 120.30 123.32 A A A NE CZ NH1 ARG ARG ARG 4 4 4 N 1 -4.42 0.60 121.00 116.58 A A A CB CG CD2 TYR TYR TYR 98 98 98 N 2 -3.99 0.60 121.00 117.01 A A A CB CG CD1 TYR TYR TYR 25 25 25 N 2 -3.91 0.60 121.00 117.09 A A A CB CG CD2 TYR TYR TYR 91 91 91 N 3 -3.78 0.60 121.00 117.22 A A A CB CG CD2 TYR TYR TYR 25 25 25 N 3 -4.79 0.60 121.00 116.21 A A A CB CG CD2 TYR TYR TYR 91 91 91 N 4 -3.71 0.60 121.00 117.29 A A A CB CG CD2 TYR TYR TYR 11 11 11 N 4 3.23 0.50 120.30 123.53 A A A NE CZ NH1 ARG ARG ARG 16 16 16 N 4 -4.39 0.60 121.00 116.61 A A A CB CG CD2 TYR TYR TYR 25 25 25 N 5 3.07 0.50 120.30 123.37 A A A NE CZ NH1 ARG ARG ARG 4 4 4 N 5 -3.66 0.60 121.00 117.34 A A A CB CG CD1 TYR TYR TYR 25 25 25 N 1 A GLN 18 53.33 -139.14 1 A VAL 20 -54.13 99.91 1 A MET 24 63.90 -57.19 1 A THR 46 -64.83 83.52 1 A THR 48 -102.61 -169.52 1 A LEU 65 71.01 -36.74 1 A LYS 67 -61.73 99.64 1 A SER 72 -178.66 -68.55 1 A ARG 77 68.39 112.87 1 A ASN 82 69.44 90.35 1 A ILE 86 -126.07 -159.93 1 A LYS 88 59.01 157.34 1 A GLU 90 -83.04 34.55 1 A ASN 93 59.83 176.66 1 A SER 95 -108.70 -139.53 2 A THR 2 59.75 -43.82 2 A ALA 3 69.41 -36.83 2 A LEU 6 -166.64 38.49 2 A LYS 7 -104.37 79.51 2 A ARG 16 -98.64 -79.82 2 A VAL 20 -27.91 -71.77 2 A CYS 21 64.44 -27.54 2 A PHE 22 -63.97 20.51 2 A ARG 23 -62.86 -73.38 2 A THR 42 -77.76 37.22 2 A SER 43 65.00 -50.99 2 A PRO 54 -61.30 86.85 2 A GLU 56 55.53 -88.87 2 A SER 72 67.85 124.04 2 A ASP 76 -134.74 -48.79 2 A SER 81 -120.61 -165.70 2 A ASN 82 47.67 74.06 2 A LEU 89 -67.38 76.94 2 A GLU 90 -96.34 59.29 2 A TYR 91 179.50 131.27 2 A ASN 93 -174.85 134.70 2 A ARG 97 -59.63 104.50 3 A THR 2 -75.42 46.57 3 A ALA 3 54.91 -51.92 3 A GLN 18 71.84 -30.86 3 A CYS 21 -149.04 -85.56 3 A PHE 22 58.14 -46.91 3 A ARG 23 -12.05 -81.11 3 A VAL 36 65.15 152.16 3 A THR 46 -61.16 79.97 3 A PRO 54 -15.18 82.61 3 A GLU 56 57.91 -88.29 3 A SER 70 -128.28 -74.68 3 A PRO 71 -44.12 102.39 3 A SER 73 -155.38 -66.35 3 A ARG 74 68.40 -61.52 3 A ILE 75 32.05 110.57 3 A ARG 77 -163.49 110.71 3 A ASN 79 -68.24 98.92 3 A SER 81 -92.67 -69.17 3 A LYS 88 98.55 149.05 3 A VAL 96 48.39 -178.93 4 A PRO 5 -76.71 33.62 4 A GLN 18 52.68 -110.89 4 A CYS 21 -101.43 64.98 4 A GLU 27 -73.28 -83.42 4 A THR 48 -109.77 -164.26 4 A GLU 55 -17.83 -61.87 4 A SER 66 -101.64 -109.23 4 A LYS 67 -110.22 75.61 4 A VAL 68 -128.09 -52.10 4 A SER 72 -131.19 -43.83 4 A ARG 74 -69.84 86.37 4 A ASN 82 53.82 84.89 4 A LYS 88 61.56 149.90 4 A TYR 91 154.19 150.91 4 A ASN 93 61.42 172.14 4 A VAL 96 54.95 163.62 5 A THR 2 -133.74 -82.13 5 A ALA 3 -122.63 -139.54 5 A PRO 5 -68.14 72.80 5 A VAL 20 66.98 -72.44 5 A ARG 23 -21.03 -73.82 5 A THR 42 -104.00 -130.17 5 A LYS 44 49.76 85.91 5 A VAL 68 62.01 -70.02 5 A PRO 71 -56.95 109.93 5 A ARG 74 74.10 -33.04 5 A ILE 75 58.37 -84.19 5 A ASP 76 57.76 -41.37 5 A PHE 80 -72.27 37.80 5 A LYS 88 73.08 156.32 5 A ARG 97 -6.63 123.67 THREE-DIMENSIONAL STRUCTURE OF ACYLPHOSPHATASE. REFINEMENT AND STRUCTURE ANALYSIS 1 Y N A PHE 22 A PHE 22 HELX_P A ILE 33 A ILE 33 1 H1 12 A GLU 55 A GLU 55 HELX_P A LEU 65 A LEU 65 1 H2 11 HYDROLASE(ACTING ON ACID ANHYDRIDES) HYDROLASE(ACTING ON ACID ANHYDRIDES) A SER 70 A SER 70 4 A PRO 71 A PRO 71 -10.83 ACYP2_HORSE UNP 1 1 P00818 STARPLKSVDYEVFGRVQGVCFRMYAEDEARKIGVVGWVKNTSKGTVTGQVQGPEEKVNSMKSWLSKVGSPSSRIDRTNF SNEKTISKLEYSNFSVRY 1 98 1APS 1 98 P00818 A 1 1 98 5 parallel anti-parallel parallel anti-parallel A LYS 7 A LYS 7 A VAL 13 A VAL 13 A VAL 36 A VAL 36 A THR 42 A THR 42 A THR 46 A THR 46 A GLY 53 A GLY 53 A ARG 77 A ARG 77 A THR 85 A THR 85 A ASN 93 A ASN 93 A ARG 97 A ARG 97 1 P 1